ARMISTICE CAPITAL, LLC - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 21 filers reported holding TENAX THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$334,000
-30.3%
1,965,885
+23.1%
0.01%
-25.0%
Q2 2022$479,000
-70.7%
1,597,049
-20.9%
0.01%
-75.0%
Q1 2022$1,635,000
-22.2%
2,019,9950.0%0.03%
-5.9%
Q4 2021$2,101,000
-41.2%
2,019,9950.0%0.03%
-44.3%
Q3 2021$3,575,000
-14.9%
2,019,9950.0%0.06%
-18.7%
Q2 2021$4,201,000
+9.5%
2,019,9950.0%0.08%
-14.8%
Q1 2021$3,838,000
+2.2%
2,019,9950.0%0.09%
-31.2%
Q4 2020$3,757,000
+20.8%
2,019,9950.0%0.13%
+13.3%
Q3 2020$3,111,000
+2891.3%
2,019,995
+1015.1%
0.11%
+1783.3%
Q1 2020$104,000
+2.0%
181,153
+114.2%
0.01%
-25.0%
Q4 2018$102,00084,5900.01%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
GOFEN & GLOSSBERG LLC /IL/ 3,819,170$6,760,0000.16%
ARMISTICE CAPITAL, LLC 2,019,995$3,575,0000.06%
Ikarian Capital, LLC 466,261$826,0000.06%
Octagon Capital Advisors LP 30,600$54,0000.01%
FAS Wealth Partners, Inc. 58,326$103,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 46,531$82,0000.00%
Gradient Investments LLC 1$00.00%
Hudock, Inc. 1$00.00%
Allworth Financial LP 1$00.00%
VANGUARD GROUP INC 363,069$642,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders